Naringenin as a Promising Therapeutic Agent for Gyrodactylus kobayashii in Goldfish
Journal of Fish Diseases · 2026
DOI: 10.1111/jfd.70026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fish Diseases, 2026. Verfasst von Guangshuo Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hainan Institute of Northwest A&F University, Sanya, Hainan, China. Hauptthemen laut MEDLINE: Fish Diseases, Goldfish, Trematode Infections, Trematoda. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Shenzhen Science and Technology Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Gyrodactylus spp. pose significant threats to farmed fish due to their high pathogenicity, resulting in substantial economic losses in aquaculture. Currently, treatments for gyrodactylosis primarily rely on chemical agents, the efficacy and safety of which are not always satisfactory, underscoring the urgent need for novel anthelmintic agents. In the pursuit of novel therapeutic agents, we assessed the in vivo anthelmintic efficacy of 20 natural compounds using a goldfish ( Carassius auratus )– Gyrodactylus kobayashii infection model. Among these compounds, naringenin (NAR) exhibited the highest efficacy and was selected for further investigation. In vitro results demonstrated NAR's significant anti‐parasitic activity, achieving 100% mortality at 4.0 mg/L after 60 min of exposure. Subsequent in vivo investigations revealed that the median effective concentration (EC 50 ) of NAR was 0.859 mg/L at 24 h and 0.704 mg/L at 48 h post‐treatment, with EC 100 at 2 mg/L. Additionally, NAR significantly impaired the mobility of G. kobayashii . Confocal microscopy revealed that NAR‐induced structural damage in worm tissues, including epidermal disruption and muscle dissolution. Moreover, both in vitro and in vivo exposure to NAR caused a decline in ATP levels, indicating potential impairment of energy production in G. kobayashii . Collectively, these findings establish NAR as a promising therapeutic agent for protecting farmed fish against Gyrodactylus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hainan Institute of Northwest A&F University, Sanya, Hainan, China.
- College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
- Northwest A&F University Shenzhen Research Institute, Shenzhen, Guangdong, China.
- Key Laboratory of Livestock Biology, Northwest A&F University, Yangling, Shaanxi, China.
- Engineering Research Center of the Innovation and Development of Green Fishery Drugs, Universities of Shaanxi Province, Northwest A&F University, Yangling, Shaanxi, China.
ORCID-Profile: Guangshuo Wang, Tianqiang Liu, Gaoxue Wang
Förderung
- Shenzhen Science and Technology Program
- National Natural Science Foundation of China
Zitieren
APA
Wang, G., Qin, J., Jin, Y., Luan, X., Qu, S., Liu, T., Ling, F., & Wang, G. (2026). Naringenin as a Promising Therapeutic Agent for Gyrodactylus kobayashii in Goldfish. Journal of Fish Diseases. https://doi.org/10.1111/jfd.70026
Vancouver
Wang G, Qin J, Jin Y, Luan X, Qu S, Liu T, et al. Naringenin as a Promising Therapeutic Agent for Gyrodactylus kobayashii in Goldfish. Journal of Fish Diseases. 2026. doi:10.1111/jfd.70026
BibTeX
@article{Wang2026,
author = {Wang, Guangshuo and Qin, Jiacheng and Jin, Yingjie and Luan, Xiaofa and Qu, Shenye and Liu, Tianqiang and Ling, Fei and Wang, Gaoxue},
title = {Naringenin as a Promising Therapeutic Agent for Gyrodactylus kobayashii in Goldfish},
journal = {Journal of Fish Diseases},
year = {2026},
doi = {10.1111/jfd.70026}
}
EUVIMED